Center of Excellence in Regulatory Science and Innovation

Boosting the safety of bulk drug substances is aim of FDA measures

25 July 2018 | By Mike Stones

Boosting the safety of compounded drugs is the aim of new plan from the US Food and Drug Administration (FDA), which has unveiled a series of measures.